Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
501
-
502
Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
Published 2025-02-01Get full text
Article -
503
-
504
-
505
A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
Published 2025-02-01“…Additionally, Kaplan-Meier survival curves were plotted to show the stratification ability of the risk groups.Results: Eastern Cooperative Oncology Group performance status (ECOG-PS), albumin, and two inflammatory biomarkers D-Dimer, and neutrophil-to-lymphocyte ratio (NLR)—were independent predictors of inferior OS. …”
Get full text
Article -
506
Short-term results of laparoscopic and open complete mesocolic excision with D3 lymph node dissection for left-sided colon cancer
Published 2016-08-01“…Morphological scores indicate identical efficacy in achievement of radical treatment for laparoscopic and open techniques from the standpoint of modern oncology principles. However, correct estimation of long-term outcomes require further studies.…”
Get full text
Article -
507
-
508
-
509
-
510
Correlation pain-quality of life in women after being submitted to surgical treatment of breast cancer
Published 2014-04-01“…The sample consisted of 49 women with a mean age of 53.9 ± 8.8 years, treated in Specialized Oncology Centers in the region. There was no significant difference between the pain domains compared to other domains. …”
Get full text
Article -
511
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Published 2024-02-01Get full text
Article -
512
-
513
Selective epithelial expression of KRASG12D in the Oncopig pancreas drives ductal proliferation and desmoplasia that is accompanied by an immune response
Published 2025-02-01“…Abstract Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge in oncology, characterized by a high mortality rate, largely attributable to delayed diagnosis and the intricacies of its tumor microenvironment. …”
Get full text
Article -
514
The Effects of Adverse Events and Associated Costs on Value-Based Care for Metastatic Pancreatic Ductal Adenocarcinoma
Published 2024-12-01“…**Background:** Rising oncology healthcare costs have led to value-based care reimbursement models that coordinate care and improve quality while reducing overall spending. …”
Get full text
Article -
515
-
516
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
Published 2015-01-01“…Data were collected by 48 physicians from oncology (patient N=344) and 8 physicians from urology (patient N=50) practices. …”
Get full text
Article -
517
A Bibliometric Analysis of Medullary Thyroid Carcinoma From 2000 to 2022
Published 2024-07-01Get full text
Article -
518
A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline
Published 2014-07-01Get full text
Article -
519
-
520